Skip to main content

Table 5 Clinical endpoints and viral reactivation: univariate analysis

From: Epstein–Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19

 

Any viral reactivation

CMV

EBV

HSV-1

In-hospital death

2.36 (1.10–5.07)

P = 0.027

1.79 (0.84–3.81)

P = 0.127

1.34 (0.62–2.889)

P = 0.455

1.37 (0.65–2.88)

P = 0.402

ICU–BSI

2.05 (0.97–4.35)

P = 0.060

2.05 (0.97–4.31)

P = 0.059

2.23 (1.04–4.79)

P = 0.040

1.15 (0.56–2.37)

P = 0.696

VAP

2.61 (1.22–5.59)

P = 0.013

2.23 (1.06–4.72)

P = 0.035

1.81 (0.85–3.88)

P = 0.122

1.61 (0.78–3.32)

P = 0.195

  1. Data are shown as odds ratio (95% confidence interval)
  2. ICU–BSI (Intensive Care Unit Bloodstream Infections), VAP (Ventilator-Associated Pneumonia), CMV (Cytomegalovirus), EBV (Epstein–Barr Virus), HSV-1 (Herpes Simplex Virus 1)